Emerging Therapy

Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

Optimism Grows for Toddlers with Peanut Allergies as Viaskin Patch Safety Study Begins

Study to Reduce Infants’ Life-Threatening Food Allergies at Risk Due to Federal Cuts

FAF Funding Four New Food Allergy Research Projects Working Toward Finding Treatments and a Cure

Dupilumab Lowered IgE Levels in Small Study

Children’s Response to Peanut Patch Therapy Increased Over 60 Months

Study: Drug Increases Speed and Safety of OIT for Multiple Allergies

Phase I Trial of Epinephrine Nasal Spray for Anaphylaxis Begins

Study: The Effect of OIT in Severe Milk, Peanut and Egg...

Positive Safety Results Reported for Viaskin Peanut Phase III Trial

Study: Nine Children Suffer Severe Symptoms in OIT Trial

Viaskin Peanut Phase III Trial Falls Short, Still Chance for FDA...

Aimmune, Regeneron and Sanofi Collaborate on Combination Peanut Therapy

Eczema Drug Makes Significant Progress as EoE Treatment

DBV Completes Phase III Study of Peanut Patch

Study: Peanut Oral Immunotherapy Combined with Probiotic Achieves Lasting Results

Your School On Our Map

Put Your School on the Map